We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

0 hedge funds and large institutions have $0 invested in Audentes Therapeutics, Inc in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 186 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1880 (-188)

100% less funds holding in top 10

Funds holding in top 10: 190 (-19)

100% less capital invested

Capital invested by funds: $2.57B → $0 (-$2.57B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 186

Holders
Holders Change
-188
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
186
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
151
Wolverine Asset Management
Illinois
-$424K -7,091 Closed
CL
152
CSS LLC
Illinois
-$419K -7,000 Closed
Jennison Associates
153
Jennison Associates
New York
-$418K -6,977 Closed
AIM
154
Aigen Investment Management
New York
-$407K -6,796 Closed
PRC
155
Pearl River Capital
Michigan
-$372K -6,213 Closed
QT
156
Quantamental Technologies
New York
-$372K -6,213 Closed
Two Sigma Investments
157
Two Sigma Investments
New York
-$359K -6,003 Closed
Bank of Montreal
158
Bank of Montreal
Ontario, Canada
-$339K -5,668 Closed
MWM
159
Mission Wealth Management
California
-$339K -5,661 Closed
HSBC Holdings
160
HSBC Holdings
United Kingdom
-$312K -5,197 Closed
Mitsubishi UFJ Asset Management
161
Mitsubishi UFJ Asset Management
Japan
-$302K -5,041 Closed
Rockefeller Capital Management
162
Rockefeller Capital Management
New York
-$301K -5,030 Closed
SL
163
Signition LP
New York
-$285K -4,762 Closed
GC
164
Guggenheim Capital
Illinois
-$276K -4,609 Closed
Nisa Investment Advisors
165
Nisa Investment Advisors
Missouri
-$263K -4,388 Closed
AIP
166
Ameritas Investment Partners
Nebraska
-$235K -3,930 Closed
VFA
167
Values First Advisors
Tennessee
-$227K -3,791 Closed
QSS
168
Quantitative Systematic Strategies
Florida
-$218K -3,651 Closed
QT
169
Quantbot Technologies
New York
-$209K -3,500 Closed
Zurich Cantonal Bank
170
Zurich Cantonal Bank
Switzerland
-$179K -2,990 Closed
SO
171
STRS Ohio
Ohio
-$155K -2,600 Closed
Canada Life
172
Canada Life
Manitoba, Canada
-$149K -2,508 Closed
TIM
173
Tortoise Investment Management
New York
-$148K -2,480 Closed
MCP
174
Maso Capital Partners
Hong Kong
-$136K -2,280 Closed
SGAM
175
Smith Group Asset Management
Texas
-$94K -1,570 Closed

BOLD Hedge Fund Activity: Q1 2020 in Review

0 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q1 2020, worth a combined $0 — down 100% from $2.57B a quarter earlier.

Sellers outnumbered buyers: 186 funds closed out of BOLD and 0 opened new positions — a net loss of 186 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $220M sold.

  • 0 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q1 2020, down from 188 in Q4 2019.
  • Funds reported $0 of Audentes Therapeutics, Inc stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Audentes Therapeutics, Inc positions in Q1 2020 and 186 closed out, a net change of -186 holders.
  • The largest Audentes Therapeutics, Inc seller in Q1 2020 was BlackRock, an estimated $220M sold.

Based on aggregated 13F filings for Q1 2020.